Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

58 trials with published results (9%)

Research Maturity

415 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.2%

35 terminated out of 679 trials

Success Rate

92.2%

+5.7% vs benchmark

Late-Stage Pipeline

11%

77 trials in Phase 3/4

Results Transparency

14%

58 of 415 completed with results

Key Signals

58 with results92% success35 terminated

Data Visualizations

Phase Distribution

554Total
Not Applicable (356)
Early P 1 (2)
P 1 (25)
P 2 (94)
P 3 (33)
P 4 (44)

Trial Status

Completed415
Unknown110
Recruiting58
Terminated35
Not Yet Recruiting32
Withdrawn13

Trial Success Rate

92.2%

Benchmark: 86.5%

Based on 415 completed trials

Clinical Trials (679)

Showing 20 of 20 trials
NCT05680766Not ApplicableRecruitingPrimary

Feasibility Assessment of Cardiovascular Endurance Training for the Symptomatic Improvement of Irritable Bowel Syndrome Patients With a Sedentary and Non-active Lifestyle.

NCT07545759Phase 2Not Yet RecruitingPrimary

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

NCT07560345Not ApplicableNot Yet RecruitingPrimary

EFFECT OF NEURODYNAMIC MOBILIZATION OF VAGUS NERVE ON IRRITABLE BOWEL SYNDROME IN WOMEN

NCT06639984Phase 2RecruitingPrimary

Psyllium in Pediatric IBS

NCT06866106Not ApplicableRecruitingPrimary

Well-being in IBS: Strengths and Happiness (WISH) 2.0

NCT07545772Phase 2Not Yet RecruitingPrimary

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

NCT02973542Phase 2CompletedPrimary

Ethosuximide to Treat IBS

NCT07539051Not Yet Recruiting

Psychoemotional Status and Functional Gastrointestinal Disorders

NCT03678935Not ApplicableCompleted

Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients

NCT07533500Not ApplicableNot Yet RecruitingPrimary

Effect of Autogenic Relaxation Training on Irritable Bowel Syndrome In Adult Females

NCT07522255Phase 3Not Yet Recruiting

Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders

NCT06847360Not ApplicableRecruiting

Home-based Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for IBS Pain

NCT04364750Early Phase 1CompletedPrimary

Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome

NCT05725954Not ApplicableWithdrawnPrimary

GUT LINK: A Study of a Care Pathway Across Primary and GI Specialty Care

NCT07519395Phase 2Not Yet RecruitingPrimary

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

NCT03664531Not ApplicableCompletedPrimary

Dietary Triggers of Gastrointestinal Symptoms in IBS Patients

NCT06923800Not ApplicableRecruiting

Exercise Interventions and Dietary Advice in Fibromyalgia and IBS

NCT07494968Not ApplicableNot Yet RecruitingPrimary

Defining Objective Markers of Compliance for Dietary Therapies in IBS

NCT06166563Not ApplicableCompleted

Exercise, Irritable Bowel Syndrome and Fibromyalgia

NCT05307185Not ApplicableCompletedPrimary

Tritordeum-based Foods for IBS Symptoms

Scroll to load more

Research Network

Activity Timeline